Author

Wei-Xin Zhao

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

A systematic review and network meta-analysis of first-line EGFR-TKI-based combination strategies for EGFR-mutant non-small cell lung cancer with brain metastases

Brain metastases are common in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) and remain clinically challenging despite the improved central nervous system activity of third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs). Because direct comparisons between active first-line c...

Jia-Yu Ma, Wei-Xin Zhao, Wan-Jing Guo et al. · Scientific Reports · 0 citations

Review Open access Aug 2026

Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials

Background Antibody-drug conjugates (ADCs) are being evaluated in advanced small cell lung cancer (SCLC), but the available trials include different targets, constructs, doses, and treatment settings. We aimed to determine the overall range of reported activity and safety while clarifying whether the evidence supports...

Pei-Pei Zhang, Wei-Xin Zhao, Jia-Yu Ma et al. · Translational Cancer Researc... · 0 citations

Open access Sep 2026

Transmembrane glycoprotein BSG serves a dual role as a prognostic and immunological modulator in the tumor microenvironment of lung adenocarcinoma

Experimental validation confirms BSG's protein expression and prognostic relevance in LUAD and indicates that high BSG expression is an independent prognostic factor for poor survival in LUAD.

Xiao-Fei Zhang, Q. Peng, Wen-Lang Zhu et al. · Translational Oncology · 0 citations